Company · CIK 0001563577 · SIC 2834 — Pharmaceutical Preparations
Galera Therapeutics, Inc. · GRTX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 DForm 4 → | Aug 5, 5:16 pm EDT | Mel SorensenPresident and CEO, Director | 975 | — | — | 0 | — | |
| Aug 3, 2026 DForm 4 → | Aug 5, 4:22 pm EDT | Lawrence M AllevaDirector | 51 | — | — | 0 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 DForm 4 → | Aug 5, 5:16 pm EDT | Mel SorensenPresident and CEO, Director | 30,000 | — | — | 0 | — | |
| Aug 3, 2026 DForm 4 → | Aug 5, 4:23 pm EDT | Kevin G LokayDirector | 240 | — | — | 0 | — | |
| Aug 3, 2026 DForm 4 → | Aug 5, 4:22 pm EDT | Lawrence M AllevaDirector | 240 | — | — | 0 | — | |
| Aug 3, 2026 DForm 4 → | Aug 5, 4:19 pm EDT | Joel F. SussmanChief Accounting Officer | 10,000 | — | — | 0 | — |